CNMD vs AORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CNMD

37.2
AI Score
VS
CNMD Wins

AORT

35.9
AI Score

Investment Advisor Scores

CNMD

37score
Recommendation
AVOID NEW MONEY

AORT

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNMD AORT Winner
Forward P/E 27.1739 30.3951 CNMD
PEG Ratio 1.8437 181.5 CNMD
Revenue Growth -0.7% 9.2% AORT
Earnings Growth 633.3% 0.0% CNMD
Tradestie Score 37.2/100 35.9/100 CNMD
Profit Margin 5.4% -3.6% CNMD
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CNMD 1M: +12.9% · 3M: +3.5% AORT 1M: -6.1% · 3M: -28.5%

Current Technical Phase

CNMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $51.21

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

Fundamentals Snapshot

Metric CNMD AORT
Market Cap — —
Forward P/E 10.8 39.4
Trailing P/E 21.6 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.1% 0.0%
EPS 2.41 -0.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CNMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.